Tag: biosimilars

The global generic drug market is set to grow to over $700 billion by 2030, driven by patent expirations, aging populations, and cost pressures. Biosimilars, India, and China are leading the charge, making life-saving medications more affordable worldwide.

Specialty pharmacies manage high-cost, complex drugs for chronic conditions. When generics and biosimilars enter this space, cost savings come with clinical risks. Learn how pharmacists can safely integrate generics without compromising patient care.